Sofia, Bulgaria, July 22, 2024 – According to the requirements of art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies that for June 2024 the Company recorded a decrease in sales of 35% compared to the same month of the previous year, incl. 7% decrease in domestic sales and 49% decrease in export sales.

For the first six months of 2024, the Company recorded a decrease in sales of 8%, incl. 4% increase of domestic sales and 15% decrease in export sales.

Sofia, Bulgaria, July 1, 2024 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 27, 2024 the Company sold 7 000 (seven thousand) repurchased own shares representing 0.004% of the share capital of the Company, at a total value of BGN 41 860,00 on the Bulgarian Stock Exchange, the average price per share was BGN 5,98.